Atlas Trials

Genasense as a 2-hour Intravenous Infusion in Subjects With Solid Tumors

Clinical trial NCT00636545 · COMPLETED

Trial details

NCT number
NCT00636545
Sponsor
Genta Incorporated
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumors
Start date
2007-05-01
Primary completion
2008-03-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.